You just read:

China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share

News provided by

China SXT Pharmaceuticals, Inc.

Sep 28, 2018, 17:15 ET